Smoking cessation in people with serious mental illness

Affiliations

¹ Center for Addiction Medicine and Schizophrenia Clinical and Research Programs of the Massachusetts General Hospital Department of Psychiatry and Harvard Medical School, Boston, MA 02114, USA. Electronic address: aeevins@mgh.harvard.edu.
² Center for Addiction Medicine and Schizophrenia Clinical and Research Programs of the Massachusetts General Hospital Department of Psychiatry and Harvard Medical School, Boston, MA 02114, USA.
³ Johns Hopkins School of Medicine and Bloomberg School for Public Health, John Hopkins University, Baltimore, MD, USA.

Comment

A Eden Evins et al. Lancet Psychiatry. 2019 Jul.

. 2019 Jul;6(7):563-564.

doi: 10.1016/S2215-0366(19)30139-7. Epub 2019 Apr 10.

¹ Center for Addiction Medicine and Schizophrenia Clinical and Research Programs of the Massachusetts General Hospital Department of Psychiatry and Harvard Medical School, Boston, MA 02114, USA. Electronic address: aeevins@mgh.harvard.edu.
² Center for Addiction Medicine and Schizophrenia Clinical and Research Programs of the Massachusetts General Hospital Department of Psychiatry and Harvard Medical School, Boston, MA 02114, USA.
³ Johns Hopkins School of Medicine and Bloomberg School for Public Health, John Hopkins University, Baltimore, MD, USA.

No abstract available

Comment on

Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial.
Gilbody S, Peckham E, Bailey D, Arundel C, Heron P, Crosland S, Fairhurst C, Hewitt C, Li J, Parrott S, Bradshaw T, Horspool M, Hughes E, Hughes T, Ker S, Leahy M, McCloud T, Osborn D, Reilly J, Steare T, Ballantyne E, Bidwell P, Bonner S, Brennan D, Callen T, Carey A, Colbeck C, Coton D, Donaldson E, Evans K, Herlihy H, Khan W, Nyathi L, Nyamadzawo E, Oldknow H, Phiri P, Rathod S, Rea J, Romain-Hooper CB, Smith K, Stribling A, Vickers C. Gilbody S, et al. Lancet Psychiatry. 2019 May;6(5):379-390. doi: 10.1016/S2215-0366(19)30047-1. Epub 2019 Apr 8. Lancet Psychiatry. 2019. PMID: 30975539 Free PMC article. Clinical Trial.

1. Gilbody S, Peckham E, Bailey D, et al. Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial. Lancet Psychiatry 2019; published online April 8. 10.1016/S2215-0366(19)30047-1. - DOI - PMC - PubMed
1. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database Syst Rev 2013; 2: CD007253. - PMC - PubMed
1. Evins AE, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with psychotic, anxiety and mood disorders in the EAGLES trial. J Clin Psychopharmacol 2019; 39: 108–116. - PMC - PubMed
1. Chengappa KN, Perkins KA, Brar JS, et al. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2014; 75: 765–72. - PubMed
1. Evins AE, Cather C, Pratt SA, et al. Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder:a randomized clinical trial. JAMA 2014;311: 145–54. - PMC - PubMed